[Skip to Content]
[Skip to Content Landing]
Citations 0
January 12, 2005

Trial Registration: Ignored to Irresistible

JAMA. 2005;293(2):158. doi:10.1001/jama.293.2.158-b

To the Editor: In his Commentary,1 Dr Rennie asks, “Can manufacturers produce a worthwhile register?” As a pharmaceutical company that has created a register to communicate the results of clinical trials of our marketed products, GlaxoSmithKline (GSK) would like to bring to your attention the actions we have taken to make our register worthwhile to the medical profession and others with an interest in clinical research.

First Page Preview View Large
First page PDF preview
First page PDF preview